Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Sep 21, 2012; 18(35): 4944-4958
Published online Sep 21, 2012. doi: 10.3748/wjg.v18.i35.4944
Published online Sep 21, 2012. doi: 10.3748/wjg.v18.i35.4944
Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?
Chen Sun, De-Quan Wu, Department of Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150086, Heilongjiang Province, China
Chen Sun, Daniel Ansari, Roland Andersson, Department of Surgery, Clinical Sciences Lund, Lund University, Skåne University Hospital, SE-22185 Lund, Sweden
Author contributions: Sun C and Ansari D performed the majority of the study and wrote the manuscript; Andersson R and Wu DQ conceived the study and finalized the revision; all authors read and approved the final manuscript.
Correspondence to: De-Quan Wu, MD, PhD, Department of Surgery, Second Affiliated Hospital of Harbin Medical University, Xuefu Road, Harbin 150086, Heilongjiang Province, China. dqwu56@163.com
Telephone: +86-451-86605535 Fax: +86-451-82524051
Received: December 17, 2011
Revised: February 1, 2012
Accepted: April 12, 2012
Published online: September 21, 2012
Revised: February 1, 2012
Accepted: April 12, 2012
Published online: September 21, 2012
Core Tip